Predictive Value of a Quick Pitt Bacteremia Score for Prognosis of Patients with Bloodstream Infection Secondary to Urinary Tract Infection: A Retrospective Cohort Study

References

• Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19(6):501–509. doi:10.1111/1469-0691.12195
   PubMed Web of Science ®Google Scholar
• Laupland KB, Church DL. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev. 2014;27(4):647–664. doi:10.1128/CMR.00002-14
   PubMed Web of Science ®Google Scholar
• National Healthcare Safety Network. Bloodstream infection event (central line-associated bloodstream infection and non-central line associated bloodstream infection). CDC:NHSN; 2022. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/7psccauticurrent.pdf. Accessed August 3, 2022.
   Google Scholar
• Arco AD, Olalla J, Latorre JD, et al. Results of an early intervention programme for patients with bacteraemia: analysis of prognostic factors and mortality. BMC Infect Dis. 2017;17(1):360.
   Web of Science ®Google Scholar
• Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents. 1999;11(1):7–12. doi:10.1016/S0924-8579(98)00060-0
   PubMed Web of Science ®Google Scholar
• Battle SE, Augustine MR, Watson CM, et al. Derivation of a quick Pitt bacteremia score to predict mortality in patients with gram-negative bloodstream infection. Infection. 2019;47(4):571–578. doi:10.1007/s15010-019-01277-7
   PubMed Web of Science ®Google Scholar
• Koppie TM, Serio AM, Vickers AJ, et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer. 2008;112(11):2384–2392. doi:10.1002/cncr.23462
   PubMed Web of Science ®Google Scholar
• Ofori-Asenso R, Zomer E, Chin KL, et al. Effect of comorbidity assessed by the Charlson comorbidity index on the length of stay, costs and mortality among older adults hospitalised for acute stroke. Int J Environ Res Public Health. 2018;15(11):11. doi:10.3390/ijerph15112532
   Web of Science ®Google Scholar
• Rac H, Gould AP, Bookstaver PB, et al. Evaluation of early clinical failure criteria for gram-negative bloodstream infections. Clin Microbiol Infect. 2020;26(1):73–77. doi:10.1016/j.cmi.2019.05.017
   PubMed Web of Science ®Google Scholar
• Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–332. doi:10.1016/j.ajic.2008.03.002
   PubMed Web of Science ®Google Scholar
• National Healthcare Safety Network. Urinary tract infection (Catheter-Associated Urinary Tract Infection [CAUTI] and Non-Catheter-Associated Urinary Tract Infection [UTI]) Events. CDC:NHSN; 2022. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/7psccauticurrent.pdf. Accessed August 3, 2022.
   Google Scholar
• Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med. 1989;87(5):540–546. doi:10.1016/s0002-9343(89)80611-4
   PubMed Web of Science ®Google Scholar
• Al-Hasan MN, Baddour LM. Resilience of the Pitt Bacteremia Score: 3 decades and counting. Clin Infect Dis. 2020;70(9):1834–1836. doi:10.1093/cid/ciz535
   PubMed Web of Science ®Google Scholar
• Wu C-J, Lee H-C, Chang -T-T, et al. Aeromonas spontaneous bacterial peritonitis: a highly fatal infectious disease in patients with advanced liver cirrhosis. J Formos Med Assoc. 2009;108(4):293–300. doi:10.1016/S0929-6646(09)60069-3
   Web of Science ®Google Scholar
• Chakhtoura NGE, Saade E, Wilson BM, et al. A 17-year nationwide study of Burkholderia cepacia complex bloodstream infections among patients in the United States veterans health administration. Clin Infect Dis. 2017;65(8):1253–1259. doi:10.1093/cid/cix559
   Web of Science ®Google Scholar
• Shen LS, Chan L, Zhu B, et al. Bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae: a single-center retrospective study on risk factors and therapy options. Microbial Drug Resist. 2021;27(2):227–233. doi:10.1089/mdr.2019.0455
   Web of Science ®Google Scholar
• Rhee J-Y, Kwon KT, Ki HK, et al. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the acute physiology and chronic health evaluation II scoring systems. Shock. 2009;31(2):146–150. doi:10.1097/SHK.0b013e318182f98f
   PubMed Web of Science ®Google Scholar
• Jorgensen SCJ, Lagnf AM, Bhatia S, Rybak MJ. A new simplified predictive model for mortality in methicillin-resistant Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2019;38(5):843–850. doi:10.1007/s10096-018-03464-0
   Web of Science ®Google Scholar
• Battle SE, Shuping M, Withers S, et al. Prediction of mortality in Staphylococcus aureus bloodstream infection using quick Pitt bacteremia score. J Infect. 2021;84(2):131–135. doi:10.1016/j.jinf.2021.12.002
   Web of Science ®Google Scholar
• Madrazo M, Piles L, López‑Cruz I, et al. Comparison of quick Pitt to quick sofa and sofa scores for scoring of severity for patients with urinary tract infection. Intern Emerg Med. 2022. doi:10.1007/s11739-022-02927-9
   Web of Science ®Google Scholar
• Henderson H, Luterbach CL, Cober E, et al. The Pitt Bacteremia Score predicts mortality in nonbacteremic infections. Clin Infect Dis. 2020;70(9):1826–1833. doi:10.1093/cid/ciz528
   PubMed Web of Science ®Google Scholar
• Fortin E, Rocher I, Frenette C, et al. Healthcare-associated bloodstream infections secondary to a urinary focus: the Quebec provincial surveillance results. Infect Control Hosp Epidemiol. 2012;33(5):456–462.
   Web of Science ®Google Scholar
• Fitzpatrick JM, Biswas JS, Edgeworth JD, et al. Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals. Clin Microbiol Infect. 2016;22(3):244–251. doi:10.1016/j.cmi.2015.10.034
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Hsueh PR, Mendes RE, et al. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2019;63(7). doi:10.1128/AAC.00355-19
   PubMed Web of Science ®Google Scholar
• Mark DG, Hung YY, Salim Z, et al. Third-generation cephalosporin resistance and associated discordant antibiotic treatment in emergency department febrile urinary tract infections. Ann Emerg Med. 2021;78(3):357–369. doi:10.1016/j.annemergmed.2021.01.003
   Web of Science ®Google Scholar
• Wiedemann B, Heisig A, Heisig P. Uncomplicated urinary tract infections and antibiotic resistance-epidemiological and mechanistic aspects. Antibiotics. 2014;3(3):341–352. doi:10.3390/antibiotics3030341
   Google Scholar
• Lee C-C, Lee C-H, Hong M-Y, et al. Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia. Crit Care. 2017;21(1):119. doi:10.1186/s13054-017-1696-z
   PubMed Web of Science ®Google Scholar
• Son JS, Song J-H, Ko KS, et al. Bloodstream infections and clinical significance of healthcare-associated bacteremia: a multicenter surveillance study in Korean hospitals. J Korean Med Sci. 2010;25(7):992–998. doi:10.3346/jkms.2010.25.7.992
   PubMed Web of Science ®Google Scholar
• Al-Hasan MN, Wilson JW, Lahr BD, et al. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob Agents Chemother. 2009;53(4):1386–1394. doi:10.1128/AAC.01231-08
   PubMed Web of Science ®Google Scholar
• Cain SE, Kohn J, Bookstaver PB, et al. Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis. Antimicrob Agents Chemother. 2015;59(1):245–250. doi:10.1128/AAC.03935-14
   PubMed Web of Science ®Google Scholar
• Harris PNA, Tambyah PA, Lye DC, et al. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320(10):984–994. doi:10.1001/jama.2018.12163
   PubMed Web of Science ®Google Scholar